The safety of antivirals and neutralising monoclonal antibodies used in prehospital treatment of Covid-19.

Katie BechmanAmelia Ca GreenMark D RussellZijing YangBang ZhengSam NortonRebecca M SmithAmir MehrkarSebastian C J BaconBen GoldacreBrian MacKennaJames B Gallowaynull null

Published in: The Journal of infection (2024)

Sotrovimab, paxlovid and molnupiravir demonstrate acceptable safety profiles. Although the risk of AEs was greatest with sotrovimab, event rates were lower than comparative pre-pandemic period.

Keyphrases

coronavirus disease
sars cov
cardiac arrest
combination therapy
emergency medical